2,505 HCA Healthcare, Inc. $HCA Shares Acquired by Woodmont Investment Counsel LLC

Woodmont Investment Counsel LLC boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 4.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 57,138 shares of the company’s stock after buying an additional 2,505 shares during the period. HCA Healthcare makes up 1.3% of Woodmont Investment Counsel LLC’s holdings, making the stock its 20th biggest holding. Woodmont Investment Counsel LLC’s holdings in HCA Healthcare were worth $24,383,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Mirae Asset Global Investments Co. Ltd. acquired a new position in HCA Healthcare in the third quarter valued at approximately $16,544,000. Vise Technologies Inc. boosted its holdings in shares of HCA Healthcare by 17.5% during the 3rd quarter. Vise Technologies Inc. now owns 18,023 shares of the company’s stock worth $7,691,000 after buying an additional 2,690 shares in the last quarter. Cidel Asset Management Inc. grew its position in shares of HCA Healthcare by 5.6% during the 3rd quarter. Cidel Asset Management Inc. now owns 1,673 shares of the company’s stock worth $714,000 after buying an additional 88 shares during the period. Invera Wealth Advisors LLC increased its stake in shares of HCA Healthcare by 8.4% in the 3rd quarter. Invera Wealth Advisors LLC now owns 2,393 shares of the company’s stock valued at $1,021,000 after acquiring an additional 185 shares in the last quarter. Finally, MGO One Seven LLC lifted its position in shares of HCA Healthcare by 34.8% during the 3rd quarter. MGO One Seven LLC now owns 1,575 shares of the company’s stock valued at $672,000 after acquiring an additional 407 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 0.1%

Shares of NYSE:HCA opened at $472.94 on Monday. The business’s 50 day moving average is $437.44 and its 200 day moving average is $444.90. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The stock has a market cap of $98.79 billion, a price-to-earnings ratio of 15.67, a PEG ratio of 1.58 and a beta of 1.11.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, beating analysts’ consensus estimates of $6.65 by $0.57. The business had revenue of $19.85 billion during the quarter, compared to analyst estimates of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. HCA Healthcare’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.96 EPS. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 30.15 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Stockholders of record on Tuesday, December 15th will be issued a $0.78 dividend. The ex-dividend date is Tuesday, December 15th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio is currently 10.34%.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on HCA shares. Morgan Stanley reduced their price target on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a report on Monday, July 27th. Jefferies Financial Group set a $450.00 price objective on shares of HCA Healthcare in a research report on Tuesday, July 14th. BMO Capital Markets began coverage on HCA Healthcare in a research note on Tuesday, September 22nd. They issued an “outperform” rating and a $495.00 target price for the company. The Goldman Sachs Group dropped their price target on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a research note on Tuesday, July 28th. Finally, Wells Fargo & Company increased their price target on HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a report on Monday, August 3rd. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $475.70.

About HCA Healthcare

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.